Rodolfo Daniel Cervantes

Title(s)Postdoctoral Scholar, Pharmacology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0002-6599-7994 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma. Cancer Lett. 2025 Jan 16; 612:217467. Sato K, Faraji F, Cervantes-Villagrana RD, Wu X, Koshizuka K, Ishikawa T, Iglesias-Bartolome R, Chen L, Miliani de Marval PL, Gwaltney SL, Adler B, Gutkind JS. PMID: 39826667.
      View in: PubMed   Mentions:    Fields:    
    2. Betaglycan sustains HGF/Met signaling in lung cancer and endothelial cells promoting cell migration and tumor growth. Heliyon. 2024 May 15; 10(9):e30520. Cervantes-Villagrana RD, Mendoza V, Hinck CS, de la Fuente-León RL, Hinck AP, Reyes-Cruz G, Vázquez-Prado J, López-Casillas F. PMID: 38756586; PMCID: PMC11096750.
      View in: PubMed   Mentions:
    3. Akt Is Controlled by Bag5 through a Monoubiquitination to Polyubiquitination Switch. Int J Mol Sci. 2023 Dec 15; 24(24). Bracho-Valdés I, Cervantes-Villagrana RD, Beltrán-Navarro YM, Olguín-Olguín A, Escobar-Islas E, Carretero-Ortega J, Olivares-Reyes JA, Reyes-Cruz G, Gutkind JS, Vázquez-Prado J. PMID: 38139359; PMCID: PMC10743781.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    4. Oncogenic Gaq activates RhoJ through PDZ-RhoGEF. Int J Mol Sci. 2023 Oct 29; 24(21). Cervantes-Villagrana RD, Color-Aparicio VM, Castillo-Kauil A, García-Jiménez I, Beltrán-Navarro YM, Reyes-Cruz G, Vázquez-Prado J. PMID: 37958718; PMCID: PMC10647656.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Cytotoxic and Antitumor Effects of the Hydroalcoholic Extract of Tagetes erecta in Lung Cancer Cells. Molecules. 2023 Oct 12; 28(20). González ASC, Valencia MG, Cervantes-Villagrana RD, Zapata AB, Cervantes-Villagrana AR. PMID: 37894532; PMCID: PMC10609614.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    6. TP53 and its Regulatory Genes as Prognosis of Cutaneous Melanoma. Cancer Inform. 2023; 22:11769351231177267. Khan SU, Ullah Z, Shaukat H, Unab S, Jannat S, Ali W, Ali A, Irfan M, Khan MF, Cervantes-Villagrana RD. PMID: 37667731; PMCID: PMC10475268.
      View in: PubMed   Mentions: 2  
    7. Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer. Cell Signal. 2023 Sep; 109:110749. Cervantes-Villagrana RD, García-Jiménez I, Vázquez-Prado J. PMID: 37290677.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    8. The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling. Life Sci. 2022 Jul 15; 301:120596. Calvillo-Robledo A, Cervantes-Villagrana RD, Morales P, Marichal-Cancino BA. PMID: 35500681.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    9. Gβγ mediates activation of Rho guanine nucleotide exchange factor ARHGEF17 that promotes metastatic lung cancer progression. J Biol Chem. 2022 01; 298(1):101440. García-Jiménez I, Cervantes-Villagrana RD, Del-Río-Robles JE, Castillo-Kauil A, Beltrán-Navarro YM, García-Román J, Reyes-Cruz G, Vázquez-Prado J. PMID: 34808208; PMCID: PMC8703085.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    10. Gβγ recruits and activates P-Rex1 via two independent binding interfaces. Biochem Biophys Res Commun. 2021 02 05; 539:20-27. Cervantes-Villagrana RD, Beltrán-Navarro YM, García-Jiménez I, Adame-García SR, Olguín-Olguín A, Reyes-Cruz G, Vázquez-Prado J. PMID: 33412417.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    11. Gαs directly drives PDZ-RhoGEF signaling to Cdc42. J Biol Chem. 2020 12 11; 295(50):16920-16928. Castillo-Kauil A, García-Jiménez I, Cervantes-Villagrana RD, Adame-García SR, Beltrán-Navarro YM, Gutkind JS, Reyes-Cruz G, Vázquez-Prado J. PMID: 33023908; PMCID: PMC7863908.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    12. Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 2020 06 18; 5(1):99. Cervantes-Villagrana RD, Albores-García D, Cervantes-Villagrana AR, García-Acevez SJ. PMID: 32555170; PMCID: PMC7303203.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    13. Endothelial cell sprouting driven by RhoJ directly activated by a membrane-anchored Intersectin 1 (ITSN1) RhoGEF module. Biochem Biophys Res Commun. 2020 03 26; 524(1):109-116. Color-Aparicio VM, Cervantes-Villagrana RD, García-Jiménez I, Beltrán-Navarro YM, Castillo-Kauil A, Escobar-Islas E, Reyes-Cruz G, Vázquez-Prado J. PMID: 31980169.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    14. Direct targeting of Gαq and Gα11 oncoproteins in cancer cells. Sci Signal. 2019 03 19; 12(573). Annala S, Feng X, Shridhar N, Eryilmaz F, Patt J, Yang J, Pfeil EM, Cervantes-Villagrana RD, Inoue A, Häberlein F, Slodczyk T, Reher R, Kehraus S, Monteleone S, Schrage R, Heycke N, Rick U, Engel S, Pfeifer A, Kolb P, König G, Bünemann M, Tüting T, Vázquez-Prado J, Gutkind JS, Gaffal E, Kostenis E. PMID: 30890659.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    15. Protumoral bone marrow-derived cells migrate via Gβγ-dependent signaling pathways and exhibit a complex repertoire of RhoGEFs. J Cell Commun Signal. 2019 Jun; 13(2):179-191. Cervantes-Villagrana RD, Color-Aparicio VM, Reyes-Cruz G, Vázquez-Prado J. PMID: 30612298; PMCID: PMC6498369.
      View in: PubMed   Mentions: 7  
    16. cAMP-dependent activation of the Rac guanine exchange factor P-REX1 by type I protein kinase A (PKA) regulatory subunits. J Biol Chem. 2019 02 15; 294(7):2232-2246. Adame-García SR, Cervantes-Villagrana RD, Orduña-Castillo LB, Del Rio JC, Gutkind JS, Reyes-Cruz G, Taylor SS, Vázquez-Prado J. PMID: 30530493; PMCID: PMC6378977.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    17. Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gαq and Gα13 proteins. J Biol Chem. 2019 01 11; 294(2):531-546. Cervantes-Villagrana RD, Adame-García SR, García-Jiménez I, Color-Aparicio VM, Beltrán-Navarro YM, König GM, Kostenis E, Reyes-Cruz G, Gutkind JS, Vázquez-Prado J. PMID: 30446620; PMCID: PMC6333895.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    18. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB2 and GPR55 receptor activation. Possible involvement of CB2-GPR55 heteromers. Int Immunopharmacol. 2018 Nov; 64:298-307. Cruz SL, Sánchez-Miranda E, Castillo-Arellano JI, Cervantes-Villagrana RD, Ibarra-Sánchez A, González-Espinosa C. PMID: 30243065.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    19. High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population. BMC Cancer. 2017 Aug 08; 17(1):531. Gallegos-Bolaños J, Rivera-Domínguez JA, Presno-Bernal JM, Cervantes-Villagrana RD. PMID: 28789619; PMCID: PMC5549346.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    20. Gβγ Pathways in Cell Polarity and Migration Linked to Oncogenic GPCR Signaling: Potential Relevance in Tumor Microenvironment. Mol Pharmacol. 2016 Nov; 90(5):573-586. Vázquez-Prado J, Bracho-Valdés I, Cervantes-Villagrana RD, Reyes-Cruz G. PMID: 27638873.
      View in: PubMed   Mentions: 16     Fields:    
    21. Protein Kinase A (PKA) Type I Interacts with P-Rex1, a Rac Guanine Nucleotide Exchange Factor: EFFECT ON PKA LOCALIZATION AND P-Rex1 SIGNALING. J Biol Chem. 2016 Mar 18; 291(12):6182-99. Chávez-Vargas L, Adame-García SR, Cervantes-Villagrana RD, Castillo-Kauil A, Bruystens JG, Fukuhara S, Taylor SS, Mochizuki N, Reyes-Cruz G, Vázquez-Prado J. PMID: 26797121; PMCID: PMC4813559.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    22. [Susceptibility of induced sickle in samples of heterozygous hemoglobin S patients (sickle cell trait) suffering diabetes mellitus type 2]. Gac Med Mex. 2015 Nov-Dec; 151(6):757-63. Díaz-Piedra P, Cervantes-Villagrana AR, Ramos-Jiménez R, Presno-Bernal JM, Cervantes-Villagrana RD. PMID: 26581534.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. [Signaling mechanisms involved in resolution of inflammation]. Gac Med Mex. 2014 Sep-Oct; 150(5):440-9. Cervantes-Villagrana RD, Cervantes-Villagrana AR, Presno-Bernal JM. PMID: 25275846.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells